Recent global events such as COVID‐19 pandemic amid rising rates of chronic lung
diseases highlight the need for safer, simpler, and more available treatments for respiratory …

Noninvasive (NIV) and invasive mechanical ventilation (IMV) are standard therapies for
treating acute respiratory failure. Patients on IMV can suffer from ventilator induced lung …

Microfluidic lab-on-a-chip devices are changing the way that in vitro diagnostics and drug
development are conducted, based on the increased precision, miniaturization and …

Background Extracorporeal carbon dioxide removal (ECCO 2 R) systems have gained
clinical appeal as supplemental therapy in the treatment of acute and chronic respiratory …

Introduction: Extracorporeal gas exchange requires the passage of oxygen and carbon
dioxide (CO2) across an artificial membrane. Current European Union regulations do not …

Extracorporeal Membrane Oxygenation (ECMO) is a resource intensive, life-preserving
support system that has seen ever-expanding clinical indications as technology and …

Extracorporeal carbon dioxide removal (ECCO2R) is a promising strategy to manage acute
respiratory failure. We hypothesized that ECCO2R could be enhanced by ventilating the …

Extracorporeal CO 2 removal is a highly promising support therapy for patients with
hypercapnic respiratory failure but whose clinical implementation and patient benefit is …

Chronic obstructive pulmonary disease (COPD) is a common condition, with a worldwide
prevalence of 10.1% and is the third leading cause of death worldwide. Approximately half …